Ancora Holdings Group Issues Letter to H.B. Fuller Board Calling for Strategic Review

H.B. Fuller Subsidiary Identified as Offeror in Regulatory Disclosure

H.B. Fuller Medical Adhesive Technologies Inc., a wholly-owned subsidiary of H.B. Fuller Company, has been identified as an offeror in a regulatory disclosure regarding Aptitude Software Group plc.

8-K filing — FULLER H B CO (FUL)

Filed: 2026-10-22 AccNo: 0001437749-26-033155 Size: 469 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

UBS Adjusts H.B. Fuller Price Target

UBS has revised its price target for H.B. Fuller Company from $69 to $55 while maintaining a Neutral rating on the stock.

H.B. Fuller Board Unanimously Rejects Ancora’s Second Unsolicited, Non-Binding Proposal To Acquire Its Building Adhesive Solutions Unit For $1.2B-$1.4B In Cash

The Board determined that the modest offer price increase does not adequately capture the value of the BAS business, including its organic growth momentum, the significant role it plays within H.B. Fuller’s broader

Reported Earlier, H.B. Fuller Prices $850M 7.625% Senior Unsecured Notes Due 2034 At 100% Of Principal To Fund Advanced Medical Solutions Group Acquisition

Activist Ancora Comes Back With Bigger Bid For H.B. Fuller Unit

H.B. Fuller receives an increased $1.2B–$1.4B cash offer from Ancora for its BAS unit, backed by Fortress. Get the details.